The new 25,000 square foot Bioscience East building at Fitzsimons signed its first tenant, DMI BioSciences, Inc.. DMI will occupy 15,000 sq. ft. of East on 1 May 2006. With two ongoing Phase II clinical trials DMI is among the more advanced companies residing in the bioscience park campus. DMI is a privately-held biopharmaceutical company [...]